Dr P spoke about it , in his opinion second approval for the same medicine is much faster , so I believe it will not be even close to that date , of course if enrollment will go well . We hearing that enrollment for mono is going much better than for adjunct .
Did you forget about BTD? The reason they've applied for BTD, and will probably receive, is to speed up the FDA review and approval process. And given Trump's plan to streamline the FDA approval process, I don't think we'll see 2019. But given that we'll probably be bought well before the end of 2018, this is all moot anyway.
News 
Market Data 
Discover 
